stalling on glp 1 New studies find that GLP-1 drugs like Ozempic and Wegovy intended to treat diabetes and aid with weight loss may also reduce the risk of cancer spreading, improve survival rates, and even Is GLP-1 Marketing Attacking Our

This approach highlights how nutritional substrates and metabolic cofactors may influence physiological resilience during sustained pharmacological weight reduction

The studies were a setback for the optimistic view that semaglutide and other drugs used in obesity and diabetes treatment could help prevent a number of brain diseases.

GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy), liraglutide (Victoza), and tirzepatide (Mounjaro, Zepbound) have dramatically improved treatment options for Type 2 diabetes and obesity

In an interview with Danone, we explore how GLP-1 drugs are driving demand for high-protein, low-sugar and gut-health-focused products.

Learn what retatrutide does and how it affects appetite, blood sugar and energy use

We know that each consumer using GLP-1 medications is on a unique journey, but a common thread is the challenge of consuming a nutritious diet through smaller portions